Inventor

BOYS MARK LAURENCE

US17 patents

⚠️ This page may combine multiple inventors who share the name “BOYS MARK LAURENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOYS MARK LAURENCE

ARRAY BIOPHARMA INC

4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors

4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors

Protein tyrosine phosphatase inhibitors

Bicyclic fused pyridine compounds as inhibitors of TAM kinases

4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

Protein tyrosine phosphatase inhibitors

Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

Protein tyrosine phosphatase inhibitors

PFIZER

3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors

3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors

BOYS MARK LAURENCE

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors

SEARLE & CO

Asymmetric synthesis of chiral beta-amiNo acids

PHARMACIA CORP

Heteroarylalkanoic acids as integrin receptor antagonists

BURGESS LAURENCE E

5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases